control group:No intervention in the control group

Efficacy and safety of apatinib in the maintenance therapy after concurrent chemoradiotherapy in the treatment of IIIc-IVa phase cervical cancer with complete remission at the first time measurement

A controlled, open-label clinical study for the efficacy and safety of Camrelizumab combined with concurrent Chemoradiotherapy for stage IIIb-IVa cervical cancer